<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Di Marco</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>D'Ambrosio</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Brontea</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Saracco</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Lanza</surname>
    <given-names>A. G.</given-names>
   </name>
   <name>
    <surname>Forni</surname>
   </name>
   <etal/>
  </person-group>. (
  <year>2016</year>). 
  <article-title>Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: is there still an indication?</article-title>
  <source>Digestive Liver Dis.</source>
  <volume>48</volume>, 
  <fpage>650</fpage>â€“
  <lpage>655</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.dld.2016.02.004</pub-id>
  <?supplied-pmid 27012446?>
  <pub-id pub-id-type="pmid">27012446</pub-id>
 </mixed-citation>
</ref>
